insights_auto
Why is PTX down 5.56%?
Dive Deeperchevron_right
PTX:ASX
Prescient Therapeutics Ltd
A$0.051
arrow_downward
-5.56%(-0.0030) 1D
Oct 26, 4:10:16 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.05
High
A$0.05
Low
A$0.05
Mkt. cap
63.00M
Avg. vol.
814.83K
Volume
1.59M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.05
High
A$0.05
Low
A$0.05
Mkt. cap
63.00M
Avg. vol.
814.83K
Volume
1.59M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
BigGo Finance
·
10 minutes ago
SK Hynix 2x Leveraged ETF to Liquidate Three Months After Nasdaq Listing as Assets Vanish 60%
TradingView
·
1 hour ago
HBM Portfolio Company Lycia Therapeutics Raises USD 317.5 Million in Nasdaq IPO and Delivers Strong Market Debut
The Dark Side Of The Boom
·
32 minutes ago
Gold Hasn’t Forgotten the Rules. The Market Changed the Game
Yahoo Finance
·
1 hour ago
Stock Market: Will S&P 500 Open Up or Down Today?
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com